Journal
FRONTIERS IN PHYSIOLOGY
Volume 12, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fphys.2021.768411
Keywords
Saccharomyces cerevisiae; lipids; cardiolipin; Barth syndrome; pathophysiology; tafazzin
Categories
Funding
- National Institutes of Health [R01 HL 117880, R01 GM 134715, RO1 GM125082]
Ask authors/readers for more resources
Saccharomyces cerevisiae, commonly known as baker's yeast, is extensively studied in science and has been crucial in researching human diseases and lipid-related pathophysiologies. Its contribution to understanding mitochondrial phospholipid cardiolipin and Barth syndrome, as well as its impact on Alzheimer's and Parkinson's diseases, are highlighted in this review.
Saccharomyces cerevisiae, commonly known as baker's yeast, is one of the most comprehensively studied model organisms in science. Yeast has been used to study a wide variety of human diseases, and the yeast model system has proved to be an especially amenable tool for the study of lipids and lipid-related pathophysiologies, a topic that has gained considerable attention in recent years. This review focuses on how yeast has contributed to our understanding of the mitochondrial phospholipid cardiolipin (CL) and its role in Barth syndrome (BTHS), a genetic disorder characterized by partial or complete loss of function of the CL remodeling enzyme tafazzin. Defective tafazzin causes perturbation of CL metabolism, resulting in many downstream cellular consequences and clinical pathologies that are discussed herein. The influence of yeast research in the lipid-related pathophysiologies of Alzheimer's and Parkinson's diseases is also summarized.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available